Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report

<p>Small cell lung cancer (SCLC) is a highly aggressive malignancy with a poor outcome. We present the case of a 57-year-old male patient with extensive-stage (ES-SCLC) treated with chemotherapy and atezolizumab. A complete response was achieved with a long remission of ∼three years. Comprehen...

Full description

Saved in:
Bibliographic Details
Main Author: Kresimir Tomic (17632194) (author)
Other Authors: Dragana Karan Krizanac (17632197) (author), Faruk Skenderi (6616190) (author), Kristina Krpina (17632200) (author), Andrea Carapina Bilic (17632203) (author), Kristina Galic (17632206) (author), Zoran Gatalica (3353003) (author), Semir Vranic (3353012) (author)
Published: 2023
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513532072034304
author Kresimir Tomic (17632194)
author2 Dragana Karan Krizanac (17632197)
Faruk Skenderi (6616190)
Kristina Krpina (17632200)
Andrea Carapina Bilic (17632203)
Kristina Galic (17632206)
Zoran Gatalica (3353003)
Semir Vranic (3353012)
author2_role author
author
author
author
author
author
author
author_facet Kresimir Tomic (17632194)
Dragana Karan Krizanac (17632197)
Faruk Skenderi (6616190)
Kristina Krpina (17632200)
Andrea Carapina Bilic (17632203)
Kristina Galic (17632206)
Zoran Gatalica (3353003)
Semir Vranic (3353012)
author_role author
dc.creator.none.fl_str_mv Kresimir Tomic (17632194)
Dragana Karan Krizanac (17632197)
Faruk Skenderi (6616190)
Kristina Krpina (17632200)
Andrea Carapina Bilic (17632203)
Kristina Galic (17632206)
Zoran Gatalica (3353003)
Semir Vranic (3353012)
dc.date.none.fl_str_mv 2023-09-26T06:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.rmcr.2023.101920
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Comprehensive_genomic_profiling_of_a_metastatic_small_cell_lung_carcinoma_with_a_complete_and_long-term_response_to_atezolizumab_A_case_report/24805182
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Lung cancer
Small cell lung cancer
Immunotherapy
Atezolizumab
Genomic profiling
dc.title.none.fl_str_mv Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p>Small cell lung cancer (SCLC) is a highly aggressive malignancy with a poor outcome. We present the case of a 57-year-old male patient with extensive-stage (ES-SCLC) treated with chemotherapy and atezolizumab. A complete response was achieved with a long remission of ∼three years. Comprehensive genomic profiling (CGP) of the tumor revealed high tumor mutation burden (13 mutations/Mb) and mutations of TP53, RB1 and ERCC4 genes. This case study confirms that a complete response to chemoimmunotherapy may be achieved in the case of ES-SCLC. It further provides the additional value of CGP and predictive testing in the management of ES-SCLC.</p><h2>Other Information</h2> <p> Published in: Respiratory Medicine Case Reports<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.rmcr.2023.101920" target="_blank">https://dx.doi.org/10.1016/j.rmcr.2023.101920</a></p>
eu_rights_str_mv openAccess
id Manara2_58e70751b18c2cd8c0a3cf54df031ee9
identifier_str_mv 10.1016/j.rmcr.2023.101920
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/24805182
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case reportKresimir Tomic (17632194)Dragana Karan Krizanac (17632197)Faruk Skenderi (6616190)Kristina Krpina (17632200)Andrea Carapina Bilic (17632203)Kristina Galic (17632206)Zoran Gatalica (3353003)Semir Vranic (3353012)Biomedical and clinical sciencesCardiovascular medicine and haematologyOncology and carcinogenesisPharmacology and pharmaceutical sciencesLung cancerSmall cell lung cancerImmunotherapyAtezolizumabGenomic profiling<p>Small cell lung cancer (SCLC) is a highly aggressive malignancy with a poor outcome. We present the case of a 57-year-old male patient with extensive-stage (ES-SCLC) treated with chemotherapy and atezolizumab. A complete response was achieved with a long remission of ∼three years. Comprehensive genomic profiling (CGP) of the tumor revealed high tumor mutation burden (13 mutations/Mb) and mutations of TP53, RB1 and ERCC4 genes. This case study confirms that a complete response to chemoimmunotherapy may be achieved in the case of ES-SCLC. It further provides the additional value of CGP and predictive testing in the management of ES-SCLC.</p><h2>Other Information</h2> <p> Published in: Respiratory Medicine Case Reports<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.rmcr.2023.101920" target="_blank">https://dx.doi.org/10.1016/j.rmcr.2023.101920</a></p>2023-09-26T06:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.rmcr.2023.101920https://figshare.com/articles/journal_contribution/Comprehensive_genomic_profiling_of_a_metastatic_small_cell_lung_carcinoma_with_a_complete_and_long-term_response_to_atezolizumab_A_case_report/24805182CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/248051822023-09-26T06:00:00Z
spellingShingle Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
Kresimir Tomic (17632194)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Lung cancer
Small cell lung cancer
Immunotherapy
Atezolizumab
Genomic profiling
status_str publishedVersion
title Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
title_full Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
title_fullStr Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
title_full_unstemmed Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
title_short Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
title_sort Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Lung cancer
Small cell lung cancer
Immunotherapy
Atezolizumab
Genomic profiling